āshibio Raises $40M in Seed and Series A Financing to Advance Therapies for Bone and Connective Tissue Disorders

BRISBANE, Calif.–(BUSINESS WIRE)–āshibio, with a focus on bone and connective tissue disorders, exited stealth mode today with $40 million in seed and Series A financing.
Click here to view original post

Click Here to Publish/Feature Your Company or Product News with Biotech Networks